NCT04215393: An Exploratory Clinical Trial Evaluating the Tolerability and Efficacy of KH906 in Patients With Corneal Neovascularization |
|
|
| Unknown status | 1 | 39 | RoW | Conbercept eye drop, Placebo | Chengdu Kanghong Biotech Co., Ltd. | Corneal Neovascularization | 04/20 | 12/20 | | |
ChiCTR2100054501: Tolerability and Pharmacokinetics of KH906 in Single/Multiple Dosing in Healthy Subjects |
|
|
| Recruiting | 1 | 18 | | kh906 | West China Hospital of Sichuan University; Chengdu Kanghong Biotechnology Co., Ltd., Chengdu Kanghong Biotechnology Co., Ltd. | Neovascular (wet) age-related macular degeneration | | | | |
